SELLAS Life Sciences Group, Inc.
15 West 38th St., 10th Floor
New York, New York 10018
June 9, 2020
Via EDGAR
Sonia Bednarowski
United States Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | SELLAS Life Sciences Group, Inc. |
Registration Statement on Form S-1 | |
File No. 333-238799 | |
Acceleration Request |
Dear Ms. Bednarowski,
Pursuant to Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, SELLAS Life Sciences Group, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-238799), so that it may become effective at 4:00 p.m. (Washington, D.C. time) on Thursday, June 11, 2020, or as soon thereafter as practicable.
Please call Daniel A. Bagliebter, of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (212) 692-6856 with any comments or questions regarding the Registration Statement.
Very truly yours, | ||
SELLAS Life Sciences Group, Inc. | ||
/s/ Angelos M. Stergiou | ||
By: Angelos M. Stergiou, M.D., Sc.D., h.c. | ||
Its: President and Chief Executive Officer |
cc: | Barbara A. Wood, SELLAS Life Sciences Group, Inc. |
Daniel A. Bagliebter, Esq., Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. |